Synergistic activity of the new ABL-specific tyrosine kinase inhibitor STI571 and chemotherapeutic drugs on BCR-ABL-positive chronic myelogenous leukemia cells (Q32118812)
scientific article
Language:
(P31) (Q13442814)
(P304) 342-347
(P407) (Q1860)
(P433) 3
(P478) 15
(P577) Thursday, March 1, 2001
(P921) (Q974135)
(Q29496)
(Q177094)
(P1433) (Q6534498)
(P1476) "Synergistic activity of the new ABL-specific tyrosine kinase inhibitor STI571 and chemotherapeutic drugs on BCR-ABL-positive chronic myelogenous leukemia cells" (language: en)
(P2093) Topaly J
Zeller WJ
Fruehauf S
(P2860) (Q33603077)
(Q73030493)
(Q25939005)
(Q50909165)
(Q50894706)
(Q29547463)
(Q29614339)
(Q34250343)
(Q37625808)
(Q33544254)
(Q41294365)
(Q28277030)
(Q41056381)
(Q42139163)
(Q46330582)
other details
description scientific article

External Links